These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A community study of high density lipoproteins in adult noninsulin-dependent diabetics. Barrett-Connor E; Witztum JL; Holdbrook M Am J Epidemiol; 1983 Feb; 117(2):186-92. PubMed ID: 6829548 [TBL] [Abstract][Full Text] [Related]
44. [Changes in lipoprotein metabolism caused by diabetic serum factors (DS) in fibroblasts of diabetics and metabolically normal patients]. Koschinsky T; Bünting CE; Schwippert B Verh Dtsch Ges Inn Med; 1978; (84):1147-51. PubMed ID: 741912 [No Abstract] [Full Text] [Related]
45. Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis. Pyrig LA; Melman NYa ; Petrun NM; Nikulina GG; Gorelova NR Int Urol Nephrol; 1984; 16(4):361-7. PubMed ID: 6535784 [TBL] [Abstract][Full Text] [Related]
46. Diabetes and atherosclerosis. Metabolic links. Steiner G Drugs; 1988; 36 Suppl 3():22-6. PubMed ID: 3076116 [TBL] [Abstract][Full Text] [Related]
47. An antibody to low density lipoprotein in diabetics. Wardle EN Experientia; 1978 Jul; 34(7):886-7. PubMed ID: 208857 [No Abstract] [Full Text] [Related]
48. Screening for hyperlipidaemia in diabetics. al-Jubouri MA; Young RM Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():572. PubMed ID: 1444175 [No Abstract] [Full Text] [Related]
49. Breakthrough could ease life for diabetics. Nurs Stand; 1990 Jan; 4(18):10. PubMed ID: 27237889 [TBL] [Abstract][Full Text] [Related]
50. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related]
51. Effects of various lipid-lowering treatments in diabetics. Steiner G J Cardiovasc Pharmacol; 1990; 16 Suppl 9():S35-9. PubMed ID: 1710744 [TBL] [Abstract][Full Text] [Related]
52. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]